VMP 42110711000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Rizatriptan 10mg tablets
BNF code 0407041R0AAABAB
Virtual Therapeutic Moiety Rizatriptan
Date identifier became valid 28 Jul 2023
Previous product identifier 322830008
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Rizatriptan benzoate
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 363573000
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Maxalt 10mg tablets (CST Pharma Ltd)
Maxalt 10mg tablets (Lexon (UK) Ltd)
Maxalt 10mg tablets (Organon Pharma (UK) Ltd)
Maxalt 10mg tablets (Sigma Pharmaceuticals Plc)
Rizatriptan 10mg tablets (A A H Pharmaceuticals Ltd)
Rizatriptan 10mg tablets (Accord-UK Ltd)
Rizatriptan 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Rizatriptan 10mg tablets (Aspire Pharma Ltd)
Rizatriptan 10mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Rizatriptan 10mg tablets (Medihealth (Northern) Ltd)
Rizatriptan 10mg tablets (Milpharm Ltd)
Rizatriptan 10mg tablets (Tillomed Laboratories Ltd)
Virtual Medicinal Product Packs
Rizatriptan 10mg tablets 12 tablet
Rizatriptan 10mg tablets 2 tablet
Rizatriptan 10mg tablets 3 tablet
Rizatriptan 10mg tablets 6 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback